The design, synthesis, and relaxivity properties of highly soluble TACN-capped trishydroxypyridonate Gd(III) complexes are presented. Molecular mechanics modeling was used to help design a complex capable of possessing three water molecules in the inner metal coordination sphere, an attractive property for high-relaxivity MRI contrast agents. The measured relaxivities of 13.1 and 12.5 mM -1 s -1 (20 MHz, 298 K) for two TACN-capped complexes are among the highest known relaxivities of low-molecular weight Gd complexes and are consistent with three coordinated waters, an extremely fast water exchange rate and long electronic relaxation time. Luminescence measurements to confirm the number of coordinated water molecules for the first time in the HOPO series are also discussed.Magnetic Resonance Imaging (MRI) is a powerful diagnostic technique in modern medicine, and the emergence of new instrumentation and applications invites the production of contrast agents with enhanced imaging capabilities. Contrast agents are evaluated on the basis of their proton relaxivities (r 1p ), and current values for commercial agents (based on poly-(aminocarboxylate) ligands) are small (r 1p = 4 -5 mM -1 s -1 ; 20 MHz and 298 K) compared to what is theoretically possible. 2,3 To obtain the high relaxivities predicted by theory, there are several parameters that must be optimized, including: q, the number of bound waters, τ m , the mean water residence time, τ s , the metal electronic relaxation time, Correspondence to: Kenneth N. Raymond.raymond@socrates.berkeley.edu . Supporting Information Available: Detailed synthesis and characterization of 3 and of TACN-1,2-HOPO, temperature dependence of the paramagnetic contribution to the water 17 O NMR transverse relaxation rate (R 2p ) for 3, and details of the luminescence and stability measurements. This information is available free of charge via the internet at http://pubs.acs.org. Here we report stable, soluble complexes with optimal hydration, water exchange, and electronic relaxation properties, representing major advances toward that goal.
NIH Public AccessIn 1995, a Gd complex was described that showed promise as a contrast agent, Gd(TREN-1-Me-3,2-HOPO)(H 2 O) 2 (1, Figure 1). 6 The r 1p value of this hexadentate hydroxypyridinone-(HOPO) based complex was measured as twice that of commercial agents due largely to the complex's increased number of bound water molecules (q of 2 as compared to 1 for commercial agents). Importantly, the stability of this complex (a critical factor for in vivo use 7 ) is higher than that of clinical agents despite the lower ligand denticity and increase in q. Since this initial report, a series of complexes, all based on the tripodal TREN (tris-(2-aminoethyl)-amine) scaffold, has been prepared in an attempt to optimize the proton relaxation parameters and increase aqueous solubility. 8 Those complexes that show the most promising relaxometric and solubility properties rely on the TREN-capped heteropodal bis-HOPO-TAM design (2, Figure 1). For exa...